Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Deppe
Carsten Deppe, Eindhoven NL
| Patent application number | Description | Published |
|---|---|---|
| 20100072900 | SYSTEM AND METHOD FOR GENERATING LIGHT BY COLOR MIXING - The present invention relates to a method of generating light with a predetermined chromaticity value of a color gamut by color mixing of the light emitted by a plurality of light sources, each of which emits light with a primary color, the light sources being capable of emitting light with at least three primary colors, wherein at least a first and a second light source are used to emit light of at least one primary color. The object to provide a simple method of generating light with a predetermined and constant chromaticity value of a color gamut by color mixing of the light emitted by a plurality of light sources, which can even be advantageously used in display applications sequentially displaying primary colors, is achieved in that said first and said second light source emit light with different peak and/or dominant wavelengths, the chromaticity of the primary color generated by color mixing of the light emitted from said first and said second light source being adjusted to a predetermined and constant chromaticity value by controlling the ratio of intensities of said first and said second light source, and said chromaticity value of said primary-color light generated by color mixing is used to generate light by color mixing with the light of other primary color light sources. | 03-25-2010 |
Denise Dama Deppe, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120121359 | Self-Sealing Fastener - A fastener suitable for use in airplane manufacture or repair that is coated with a pre-mixed moisture cure sealant. The sealant layer is coated with a frangible moisture barrier that will break apart when the fastener is installed, thus exposing the sealant to atmospheric moisture. Once exposed to moisture, the sealant will begin to cure. Preferred embodiments also provide a moisture indicator that provides a visual indication that the outer moisture resistant layer has been damaged. | 05-17-2012 |
Holger Deppe, Basel CH
| Patent application number | Description | Published |
|---|---|---|
| 20110086836 | Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor Modulators - The present invention relates to substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention. | 04-14-2011 |
Holger Deppe, Fullinsdorf CH
| Patent application number | Description | Published |
|---|---|---|
| 20100093697 | Substituted Imidazopyridine Derivatives As Melanocortin-4 Receptor Antagonists - The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin-4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amytrophic lateral sclerosis (ALS), anxiety and depression. | 04-15-2010 |
| 20100249093 | Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators - The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amyotrophic lateral sclerosis (ALS), anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention. | 09-30-2010 |